Trials / Completed
CompletedNCT04544982
Study to Evaluate the Efficacy of Blue Fenugreek Kale Extract (BFKE) on Skin
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy of Blue Fenugreek Kale Extract (BFKE) on Skin.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Vedic Lifesciences Pvt. Ltd. · Industry
- Sex
- Female
- Age
- 30 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
Participants will be supplemented BFKE for a period of 8-weeks to improve skin health. The objective of the study is to evaluate the 'Transepidermal Water Loss (TEWL)' that characterizes the skin barrier function of stratum corneum. Additional parameters include, evaluation of skin moisture content, wrinkling, elasticity, sagging, radiance and also on inflammatory biomarkers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Blue fenugreek kale extract | One capsule to be taken orally before breakfast and one capsule after lunch, with water. |
| OTHER | Placebo | One capsule to be taken orally before breakfast and one capsule after lunch, with water. |
Timeline
- Start date
- 2020-09-01
- Primary completion
- 2021-01-30
- Completion
- 2021-03-25
- First posted
- 2020-09-10
- Last updated
- 2021-04-06
Locations
1 site across 1 country: India
Source: ClinicalTrials.gov record NCT04544982. Inclusion in this directory is not an endorsement.